|Day Low/High||15.25 / 15.80|
|52 Wk Low/High||5.75 / 16.96|
The South San Francisco, Calif.-based firm said its Phase 3 study of tirasemtiv in patients with amyotrophic lateral sclerosis did not achieve primary or secondary endpoints.
Let's take a look at several stocks that are experiencing unusual volume activity.
Stocks are higher on deals as Microsoft buys Nokia and Jarden buys Yankee Candle Company.
StockMarketMentor.com founder Dan Fitzpatrick details how to play three stocks Jim Cramer discussed on CNBC's "Mad Money" last night.